Recombinant human GRK7 protein

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The GRK7 also known as G protein-coupled receptor kinase 7 is an enzyme that specifically phosphorylates activated forms of G protein-coupled receptors (GPCRs) which leads to their desensitization. It has a molecular mass of approximately 62 kDa. GRK7 is predominantly expressed in photoreceptor cells of the retina particularly in cone cells. This localization plays a significant role in vision especially under bright light conditions and contributes to the regulation of visual signal transduction.

Biological function summary

GRK7 plays an important part in the regulation of phototransduction processes in the cone cells. It participates in the deactivation of photopigments after their activation by light facilitating the rapid response of cone cells to changes in light stimuli. GRK7 does this by becoming part of a regulatory complex that involves the phosphorylation of opsin molecules. This complex is essential for the adaptation of cone cells to different light intensities and maintaining visual acuity.

Pathways

GRK7 functions in the phototransduction cascade where it interacts with other components like rhodopsin and arrestin. The regulation of photoactivated rhodopsin by GRK7 ensures the timely deactivation of phototransduction signals. Additionally GRK7 plays a role in G protein signaling pathways influenced by its interaction with G subunit proteins. This involvement is significant for maintaining the balance in signal termination and receptor recycling within these pathways.

GRK7 is linked to disorders affecting vision such as cone dystrophy and related retinal diseases. Changes in GRK7 expression or function can disrupt normal phototransduction leading to impaired vision. Additionally interesting connections exist between GRK7 and other proteins implicated in retinal disorders like arrestin which collaborates with GRK7 in controlling the deactivation of photopigments. Understanding these interactions offers insights into developing potential therapeutic strategies for treating such visual impairments.